Business Description
Century Therapeutics Inc
NAICS : 541714
SIC : 2833
Description
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.83 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.3 | |||||
| Beneish M-Score | 1.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29 | |||||
| 3-Year EPS without NRI Growth Rate | 27.2 | |||||
| 3-Year FCF Growth Rate | 13.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.86 | |||||
| 9-Day RSI | 56.52 | |||||
| 14-Day RSI | 52.87 | |||||
| 6-1 Month Momentum % | -71.38 | |||||
| 12-1 Month Momentum % | -63.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.24 | |||||
| Quick Ratio | 9.24 | |||||
| Cash Ratio | 9.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2192.05 | |||||
| Net Margin % | -2127.33 | |||||
| ROE % | -37.67 | |||||
| ROA % | -24.57 | |||||
| ROIC % | -70.74 | |||||
| ROC (Joel Greenblatt) % | -121.15 | |||||
| ROCE % | -25.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 33 | |||||
| PB Ratio | 0.7 | |||||
| Price-to-Tangible-Book | 0.7 | |||||
| EV-to-EBIT | 0.02 | |||||
| EV-to-EBITDA | 0.03 | |||||
| EV-to-Revenue | -0.48 | |||||
| EV-to-Forward-Revenue | 1.29 | |||||
| EV-to-FCF | 0.02 | |||||
| Price-to-Net-Current-Asset-Value | 2.54 | |||||
| Price-to-Net-Cash | 2.68 | |||||
| Earnings Yield (Greenblatt) % | 5000 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IPSC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Century Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.861 | ||
| EPS (TTM) ($) | -2.15 | ||
| Beta | 0 | ||
| Volatility % | 63.38 | ||
| 14-Day RSI | 52.87 | ||
| 14-Day ATR ($) | 0.210258 | ||
| 20-Day SMA ($) | 3.23225 | ||
| 12-1 Month Momentum % | -63.68 | ||
| 52-Week Range ($) | 2.805 - 14 | ||
| Shares Outstanding (Mil) | 59.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Century Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Century Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Century Therapeutics Inc Frequently Asked Questions
What is Century Therapeutics Inc(IPSC)'s stock price today?
The current price of IPSC is $3.30. The 52 week high of IPSC is $14.00 and 52 week low is $2.81.
When is next earnings date of Century Therapeutics Inc(IPSC)?
The next earnings date of Century Therapeutics Inc(IPSC) is 2023-08-11 Est..
Does Century Therapeutics Inc(IPSC) pay dividends? If so, how much?
Century Therapeutics Inc(IPSC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers